| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |